ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182C953. A total of 3 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,120 | +7.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $107,660 | +35.5% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $79,440 | +429.6% | 2,000 | +300.0% | 0.00% | – |
| Q2 2022 | $15,000 | +150.0% | 500 | +150.0% | 0.00% | – |
| Q1 2022 | $6,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | +50.0% | 200 | +100.0% | 0.00% | – |
| Q4 2019 | $6,000 | -98.4% | 100 | -98.0% | 0.00% | -100.0% |
| Q3 2019 | $372,000 | +2225.0% | 5,100 | +2450.0% | 0.00% | – |
| Q2 2019 | $16,000 | -89.0% | 200 | -92.0% | 0.00% | -100.0% |
| Q1 2018 | $146,000 | -51.8% | 2,500 | -46.8% | 0.00% | -50.0% |
| Q4 2017 | $303,000 | +482.7% | 4,700 | +370.0% | 0.00% | – |
| Q3 2017 | $52,000 | +85.7% | 1,000 | +66.7% | 0.00% | – |
| Q2 2017 | $28,000 | -84.3% | 600 | -83.3% | 0.00% | -100.0% |
| Q1 2017 | $178,000 | +143.8% | 3,600 | +200.0% | 0.00% | +100.0% |
| Q4 2016 | $73,000 | -52.3% | 1,200 | -47.8% | 0.00% | -50.0% |
| Q3 2016 | $153,000 | -48.3% | 2,300 | -56.6% | 0.00% | -50.0% |
| Q2 2016 | $296,000 | +44.4% | 5,300 | -13.1% | 0.00% | +33.3% |
| Q1 2016 | $205,000 | +355.6% | 6,100 | +510.0% | 0.00% | +200.0% |
| Q4 2015 | $45,000 | +650.0% | 1,000 | +900.0% | 0.00% | – |
| Q2 2015 | $6,000 | +500.0% | 100 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 2,000 | $116,120 | 0.00% |
| SIMPLEX TRADING, LLC | 5,500 | $319 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |